Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Ordinary Shares, nominal value of $0.01 per share
-
Shares outstanding
-
2,461,355,158
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
1,668,061
-
Shares change
-
-127,454
-
Total reported value, excl. options
-
$15,545,000
-
Value change
-
-$1,097,988
-
Number of buys
-
7
-
Number of sells
-
3
-
Price
-
$9.32
Institutional Holders of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) as of Q2 2022
As of 30 Jun 2022 Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,668,061 shares of stock of the company.
Largest 10 holders included COMPASS GROUP LLC, Itau Unibanco Holding S.A., D. E. Shaw & Co., Inc., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, UNITED MARITIME CAPITAL LLC, Penserra Capital Management LLC, MORGAN STANLEY, and FNY Investment Advisers, LLC.
This table shows 10 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.